We also observed regional heterogeneity in genes associated with poor clinical prognosis in IDH-mutant glioma, including CDKN2A/B, CDK4, MYC, MYCN, and PDGFRA23 (Fig. 2b, Supplementary Fig. 1; Supplementary Data 1). The gene discussed is CDKN2A; the disease is central nervous system cancer.